Braskem publishes Q3 2026 earnings call transcript
BAK•Braskem reported third-quarter recurring EBITDA of US$382 million, down 63% sequentially, and operating cash generation of US$429 million, including a US$198 million working-capital release.
BAK•Braskem reported third-quarter recurring EBITDA of US$382 million, down 63% sequentially, and operating cash generation of US$429 million, including a US$198 million working-capital release.
Braskem’s November 13 earnings call reported recurring EBITDA of US$382 million, down 63% sequentially as petrochemical spreads normalized. Operating cash generation reached US$429 million, supported by a US$198 million working-capital release.
CFO Carlos Brandão said capital restructuring talks were ongoing and nonbinding, with agreement on essential commercial terms still pending. Management cited forecasts for modest fourth-quarter spread recovery but continued industry weakness in 2027 amid global overcapacity and moderate demand.